Table 2.
Small GTPase | Interacting proteins | Related diseases/function | Pathway/mechanism | References |
---|---|---|---|---|
Rit2 (Rin) | NGF | Alzheimer’s disease | Increased RAS/MAPK | Besga et al., 2017 |
Huntington’s disease | Increased AKT/mTOR | Chaldakov et al., 2009; Zhang et al., 2013 | ||
RIT1 | Noonan syndrome | Increased RAS/MAPK, Rac, and Stat3 | Yaoita et al., 2016 | |
Mental retardation, microcephaly, and epilepsy | Sonmez et al., 2017 | |||
TECR | Non-syndromic mental retardation | Increased RAS/MAPK | Caliskan et al., 2011 | |
NTRK1 | Hereditary sensory and autonomic neuropathy type V | A mutation in the NTRK1/high-affinity nerve growth factor (TrkA) gene | Houlden et al., 2001 | |
Congenital insensitivity to pain with anhidrosis | ||||
POU4F1 | Autism | Copy number variations (CNVs) | Indo, 2001 | |
Rit1 (Rit) | B-Raf | Neuronal development and regeneration | Activation of the B-Raf/ERK and p38 MAP kinase cascades | Salyakina et al., 2011 |
p38 MAPK | Neurite outgrowth and cell survival | |||
MK2 | Cell survival | Rit GTPase-p38-MK2-AKT 9 kinase survival pathway | Shi and Andres, 2005 | |
HSP27 | Cell survival | MK2 signaling complex | Shi et al., 2013 | |
Akt | Cell survival | p38–MK2–HSP27-Akt activation | Shi et al., 2011 | |
RGL3 | RalA activation | A candidate effector for Rit and Ras | Shao and Andres, 2000 | |
Rheb | mTOR | Promoting growth, cell cycle progression and inhibition of autophagy | Growth factor-induced mTORC1 activation | Sokolov et al., 2018 |
TSC complex | Form a complex with Rheb at the lysosomal membranes | Growth factor-induced mTORC1 activation | Lim and Crino, 2013 | |
PLD1 | Rheb binds and activates phospholipase D1 (PLD1) in a GTP-dependent manner | mTORC1 activation | Zheng et al., 2014 | |
GAPDH | GAPDH regulates mTOR activity by sequestering the Rheb. | Rheb–GAPDH interaction | Lee et al., 2009 | |
FKBP38 | Coordinate membrane targeting of Rheb | Rheb interacts with FKBP38 and prevents its association with mTOR | De Cicco et al., 2018 | |
RASSF1 | Rheb form complex with RASSF1A to coordinate Hippo and TOR signaling | Hippo pathway activator | Nelson and Clark, 2016 | |
NIX LC3 |
Rheb interacts with mitochondrial autophagic receptor Nix and the autophagosomal protein LC3-II. | Activation of mitophagy |
Melser et al., 2013 Sugiura et al., 2015 |
|
Syntenin | PDZ protein syntenin preferentially binds to the GDP-bound form of Rheb. | Rheb-syntenin signaling | Sato et al., 2015 | |
CAD | Rheb binds to CAD protein, a multifunctional enzyme required for the synthesis of pyrimidine nucleotides. | CAD binding is more pronounced with Rheb2 than with Rheb1 | Tyagi et al., 2015 | |
PERK | Rheb inhibits protein synthesis by activating the PERK-eIF2α signaling | Phosphorylation of eIF2α and PERK interplay | Shahani et al., 2017 | |
BACE1 | Aging and Alzheimer’s disease. Forebrain Rheb promotes aging-associated cognitive defects | Rheb depletion increased the levels of BACE1 | ||